Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Urinary beta2-microglobulin is associated with acute renal allograft rejection.

William S Oetting1, Tyson B Rogers, Thomas P Krick

  • 1Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|April 25, 2006
PubMed
Summary

Urinary beta2-microglobulin shows promise as a biomarker for noninvasive diagnosis of acute rejection (AR) in kidney transplant recipients. Further studies are needed to confirm its predictive value in larger patient cohorts.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Conference Report-The Past, Current, and Future Challenges in Transplantation: A Festschrift in Honor of Professor Paul Anthony Keown.

Canadian journal of kidney health and disease·2026
Same author

Haplotype-Based Analysis of OCA2 Variants in Oculocutaneous Albinism.

Pigment cell & melanoma research·2026
Same author

Prednisone Avoidance After Abdominal Solid Organ Transplantation: A Narrative Review.

Transplantation·2026
Same author

A Mycophenolate Pharmacokinetic Study with New Insights into Enterohepatic Recirculation in Kidney Transplant Recipients.

Clinical pharmacokinetics·2026
Same author

Twenty-Year Kidney Transplant Outcomes With Prednisone-Free Maintenance Immunosuppression: A Matched Control Analysis.

Clinical transplantation·2025
Same author

Kidney transplantation after bariatric surgery-Outcomes from a 30-year experience.

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery·2025

Area of Science:

  • Nephrology
  • Transplant Immunology
  • Biomarker Discovery

Background:

  • Noninvasive diagnosis of acute rejection (AR) in kidney allografts is crucial for timely intervention.
  • Urinary biomarkers could facilitate early AR detection and treatment, improving patient outcomes.

Purpose of the Study:

  • To identify novel urinary protein biomarkers associated with acute rejection (AR) in kidney allograft recipients.
  • To evaluate the diagnostic potential of identified biomarkers using matrix-associated laser desorption ionization time-of-flight mass spectroscopy (MALDI-TOF MS).

Main Methods:

  • Urine samples from kidney allograft recipients with and without biopsy-proven AR, kidney donors, and patients with proteinuric native kidney disease were analyzed using MALDI-TOF MS.
  • A specific protein peak identified at 11.7 kd was further characterized and validated.

Related Experiment Videos

Main Results:

  • A distinct protein peak at 11.7 kd strongly correlated with acute rejection (AR).
  • This protein was identified as beta2-microglobulin, demonstrating high sensitivity (83.3%) and specificity (80%) for AR.
  • Enzyme-linked immunosorbent assay confirmed elevated urinary beta2-microglobulin levels in patients with AR.

Conclusions:

  • Urinary beta2-microglobulin shows potential as a significant biomarker for acute rejection (AR) in kidney transplant recipients.
  • Combining beta2-microglobulin with other biomarkers may create a specific urinary protein signature for AR.
  • Validation in a larger cohort of kidney transplant recipients is recommended to confirm these findings.